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Abstract: The keratocystic odontogenic tumor is a benign intraosseous neo-
plasm derived from remnants of the dental lamina and it occurs with high 
frequency. Regarding histological characteristics, it has a high recurrence rate 
which is one of the main therapeutic problems. Also, it presents high local 
aggressiveness, expressed in cortical expansion, delayed eruption and dis-
placement of teeth, blood vessels and nerves. At present, there are various 
treatments, being ideal the one which presents the lowest risk of recurrence 
with low morbidity for the patient. In this review, the main histopathological, 
clinical and therapeutic aspects of this oral pathology are discussed.
Keywords: Keratocystic odontogenic tumor, treatment, decompression, diffe-
rential diagnose.
INTRODUCTION.
The Keratocystic Odontogenic Tumor (KCOT) is des-
cribed as a benign tumor of relatively high prevalence ori-
ginating from remnants of the dental lamina tissues. In 
2005, the World Health Organization (WHO) classified it 
as an odontogenic tumor due to a number of features which 
reflect its neoplastic nature1 since, in some cases, it may 
undergo malignant transformation (transformation into a 
squamous cell carcinoma)2. 
It is usually asymptomatic, becoming evident only as 
radiographic finding in routine evaluations or check-ups 
with panoramic radiographs. Since it has a complex opera-
tion and high recurrence, knowing its different characteris-
tics is critical to make a correct differential diagnosis and 
treatment. Such reasoning led this review of literature con-
cerning this important pathology to address topics such as 
etiopathogenesis, histopathology, diagnosis and treatment. 
EPIDEMIOLOGY AND ETIOPATHOGENESIS.
KCOT is a rare injury accounting for 4-12% of odon-
togenic cysts3,4. Though, it has become the most common 
odontogenic tumor5 after being reclassified as a tumor. It 
usually develops in the posterior mandibular area, speci-
fically in the body and mandibular ramus with a probabi-
lity of 60%. While a higher frequency is observed in the 
molar area in the jaw with 21%6, it is uncommon in the 
anterior maxilla and chin area with 8.5 and 7%, respec-
tively7 (Fig.1)8. In terms of age distribution, it presents its 
highest prevalence in the second and third decade of life. 
Despite this, age range is wide and it can appear from the 
first to the eighth decade of life3,9. Regarding gender, it 
has a higher incidence in males, reaching a ratio of 2:1 
compared to females10.
It is described as a developmental odontogenic tumor 
which can originate as an extension of the basal epithelial 
cells or the dental organ due to degeneration of the stellate 
reticulum, or odontogenic epithelial remnants in the man-
dible or maxilla. Three theories have been proposed about 
the causes for tumor growth: an increase due to basal cell 
replication, increased osmotic pressure, or release of bone-
resorbing factors (enzyme activity in osteolysis)11-12. 
It is considered that the main cause for the origin of this le-
sion is a lack of regulation and a mutation in the PTCH gene13. 
When changes occur in the PTCH gene, there is an associa-
ted increased expression of molecules such as bcl-1, p53 and 
cyclin D. Therefore, cell cycle is altered, with a growth poten-
tial and increased proliferation which would trigger KCOT 
development. This has been explained by the occurrence of 
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phenomena such as allelic losses in the cell genetic material 
involving KCOT, which leads to a loss of heterozygosity. 
This phenomenon is also found in basal cell carcinoma and 
the basal cell nevus syndrome (Gorlin-Goltz)14,15. Such featu-
re is prominent due to the association of this syndrome and 
KCOT (7%), mainly in females3. This association could be a 
common component, since the presence of repeated or mul-
tiple KCOT could be an important sign in early diagnosis. 
In many cases, this early clinical manifestation makes it pos-
sible to diagnose the syndrome3. Besides presenting multiple 
KCOT, basal cell carcinomas, spina bifida and cerebral falx 
calcification are characteristics of this syndrome3,16.
CLINICAL AND RADIOLOGICAL FEATURES. 
This kind of injury shows few symptoms and usually 
appears incidentally on X-rays. Among the symptoms, there is 
pain, enlargement and swelling due to its capacity to expand 
cortical bone, making the increase in intraoral volume 
evident. It may also be colonized and infected by pathogenic 
microorganisms, producing a subsequent drainage of purulent 
content. Besides, it can manifest ipsilateral paresthesia due to 
displacement or nerve compression17. 
The growth of this lesion has been described as mural, 
although there may be other types of tumor growth. It 
develops between the cortical bone, reabsorbing cancellous 
bone or moving through medullary spaces18, rarely drilling 
cortical bone but tending to grow in an anteroposterior 
direction19. The size of the lesion can achieve large dimensions 
and can cause a pathologic fracture20. 
In the radiological examination, it presents in various 
ways. The most common feature is a unilocular or multi-
locular radiolucent area of variable size, 5cm or more; with 
clear limits distinguishing cortical bone (possibly punctu-
red). Also, it may show scalloped edges and lobed or polycys-
tic appearance. It is common to find dental displacement, in-
cluding root resorption in teeth neighboring the tumor1,11,21.
HISTOPATHOLOGY.
In the histological examination, a wall of dense (fibrous) 
connective tissue is observed, and it can be focally separated 
from the epithelium, with no inflammatory cellular infil-
tration3. It is internally coated by a thin and constant layer 
of stratified plain parakeratinized epithelium with a thic-
kness of six to ten cellular layers21. Basal cells are cuboidal 
in palisade arrangement with polarized and hyperchromatic 
nuclei of uniform size. On the surface facing the tumoral 
lumen, it is possible to find a thin corrugated parakeratin 
layer with some cell nuclei inside. The absence of epithelial 
papilla makes the arrangement of the basement membrane 
rather flat. The capsule is thin and friable. Suprabasal ex-
pression of Ki-67 or p53 as growth markers is observed in 
the epithelium12.
Sometimes, it is possible to observe the presence of satelli-
tes cysts or tumors within the connective tissue, the epithe-
lium or the wall of the capsule21. These have been associated 
with possible recurrence events related to KCOT and varied 
rates22 ranging between 0% and 100%23 mainly due to two 
aspects: the type of treatment carried out and the length of 
time of radiological and clinical follow-up24. Another factor 
that is associated with recurrence is the tumoral membrane, 
which becomes labile at removal because it is very thin, and 
friable easily fragmenting and enabling the persistence of 
tumor remnants into the cavity or the surrounding bone tis-
sue. That makes it clear that the mere removal of the lesion 
is not always effective to prevent further KCOT occurren-
ces. Therefore, different treatments and their combination 
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Figure 1. Location of KCOTs according to frequency 
of occurrence (Attaguile et al.8, with changes.)
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vant conditions to perform a differential diagnosis with 
KCOTs are:
Dentigerous cyst: it is an osteolytic lesion which 
usually leads to misdiagnose due to the similar radio-
graphic features with KCOT, even more when it is solid 
and unicystic. The difference lies in the association of 
this lesion with teeth (canine or third molar)25 which is 
not found in KCOT. A possible delay in tooth eruption, 
apart from swelling and pain due to cortical expansion 
may be present11,20,26.
Lateral periodontal cyst: it can be confused with a 
KCOT when the latter is in the mandibular body at pre-
molar level. It is small size with clear limits and unilo-
cular aspect11,21,27.
Ameloblastoma: it has similar clinical and radiogra-
phic features with KCOT when the ameloblastoma is 
in early stages, since it can then reach large dimensions 
which produce deformities. In the histopathological 
exam, proliferative nests surrounded by cells with high 
polarization, simulating the enamel organ can be obser-
ved21,26.
Adenomatoid odontogenic tumor (AOT): it is asso-
ciated with impacted teeth and is mainly located in the 
anterior mandible and maxilla, unlike in KCOT21,26,27.
Table 1. Differential diagnoses.
Característics	 				KCOT	 Dentigerous	 Ameloblastoma	 			AOT	 Ameloblastic	 CGCG
	 	 cyst	 	 	 fibroma
Clinical aspect Variable size. Cortical Extensive  Swelling on  Cortical Cortical expan-
 Slight cortical  expansion. deformities.  an unerupted  expansion. sion or perfora-
   affection.  tooth.  tion. Ulceration.
Location Any area of the Related to Mandibular  In anterior  Mandibular  Mandibular
 mandibular body third molars  molar area  maxilla. molar area.  anterior area.
 and ramus.  and maxillary  and ascending
   canines.  ramus.
Sex Male No preference. No preference. Female. No preference. Female.
Age Second and third  Second and third  Fourth and fifth  Second decade  First to fourth  Third decade.
 decade of life. decade of life.  decade of life.  of life.  decade of life.
Signs and  Cortical expansion  Asymptomatic.   Asymptomatic.  Asymptomatic.  Asymptomatic.  Pain and
symptoms and paresthesia.  Delayed tooth     paresthesia.
  eruption. 
  There might be
  swelling or pain.
have been sought to make the therapeutic approach to these 
lesions more effective25.
Currently, a distinction has been made between true 
KCOTs and those with a similar histology, but not the same. 
In the re-classification of this condition, Philipsen1 excludes 
the orthokeratotic variable from the category of keratocystic 
odontogenic tumor, calling it orthokeratotic odontogenic 
cyst (OOC). Its characteristics are different from KCOT, 
such as the presence of orthokeratotic keratinization with a 
granulose layer10 a lower thickness of the cornea layer, and 
zero expression of proteins such as tenascin. Furthermore, 
there is a difference in the amount of synthesis of cytoke-
ratins 10, 13 and 14, which have higher concentrations in 
KCOT. A different origin for both lesions has been descri-
bed too. OOC can derive from epithelial rests of oral and 
gingival mucosa. All these different histopathologic features 
of OOC give it a less proliferative potential and a reduced 
tendency to recurrence9. Another big difference, when diag-
nosing this disease, is its high frequency and similarity with 
the dentigerous cyst both clinically and radiographically9.
DIFFERENTIAL DIAGNOSIS.
Diagnose of  KCOT is mainly done by histopatho-
logical analysis and biopsy (Table 1). Among the rele-
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Ameloblastic fibroma: like KCOT, it can expand the 
cortical bone. In the radiological examination, it is presen-
ted as a mixed lesion with radiolucent and radiopaque ima-
ges contrary to the KCOT which is a purely radiolucent le-
sion. Histologically, it has a fibrous capsule, different from 
KCOT11,21,27.
Central giant cell granuloma (CGCG): it may mislead 
to confusion since it occurs in similar age groups and 
is clinically similar to KCOT. However, it has different 
evolution times so there may be expansion or perforation of 
cortical and ulceration. Histology is different as well; since 
there is a proliferation of fibroblasts in a collagen lattice, 
besides multinucleated giant cells11,21. 
TREATMENT.
The treatments proposed for the resolution of this condi-
tion are varied and have changed over time. In the begin-
ning and in the absence of less invasive treatment options, 
total resection of the lesion was postulated as the treatment 
of choice, given that the maximum amount of diseased tissue 
was removed for clinical success. This was associated with 
high morbidity for the patient, loss of bone structure, and 
even nerve damage or weakening of bone bases. For this rea-
son, other alternatives were sought hoping to find an option 
which would respect the actual anatomical structures, lea-
ding to the least damage and the maximum benefit. This is 
only possible considering specific injury factors, such as its 
extent and location, involving degree of neighboring struc-
tures, nerves, blood vessels, teeth and soft tissues28. The state 
and the amount of remaining bone is also an important fac-
tor to consider25.
Considering the need to obtain a low morbidity for the 
patient, all treatments have been classified into two main 
groups29, (Table 2). 
Enucleation is a non invasive treatment seeking to 
eliminate all tumor tissue including its membrane17. 
Enucleation has a high recurrence rate when used as 
the only technique so it has been combined with other 
elements. Carnoy’s solution has the effect of cauterizing 
the tumor cells, and the possible adverse effect of tem-
porary nerve damage with paresthesia. This has proven 
satisfactory, although cases of recurrence have been des-
cribed in KCOTs treated this method30. In replacement 
of Carnoy’s solution, electrocautery of the area has been 
used, obtaining similar results29,31. Enucleation using li-
quid nitrogen (cryotherapy) has been tried because of the 
capacity of devitalizing the bone in the area of the lesion, 
leaving a thin layer of inorganic fabric intact. It produces 
cell death through the formation of ice crystals in and 
around the cell, generating disturbances in the osmosis 
and electrolytic balance25.
Other methods used are curettage, peripheral osteo-
tomy and marsupialization23. 
It is true that recurrence of KCOT is one of the greatest 
risks and the only treatment which has been shown to mi-
nimize it is the total bloc resection. However, undesirable 
consequences and significant morbidity for the person are 
generated, although bone block grafts to treat bone defects 
produced by the total resection have been tried29,31.
Since the treatment with the lowest recurrence rate 
generates significant morbidity for the patient, decom-
pression of KCOTs has been proposed as a treatment of 
choice because it is capable of producing lower morbidi-
ty for the subject and better results. Marsupialization, as 
described by Partsch, releases intraluminal pressure ge-
nerating a pocket to communicate the entire tumor with 
the external environment32. 
Table 2. Classification of treatments for the keratocystic 
odontogenic tumor according to Blanas et al.29,. 2000.
CONSERVATIVE	TREATMENTS		 AGGRESSIVE	TREATMENTS	
 Enucleation. Enucleation and peripheral  
 osteotomy. 
Enucleation and curettage. Enucleation and Carnoy’s  
 solution application.
Decompression and  Cryotherapy.
marsupialization.
Enucleation and  Resection without continuity  
decompression defect.
 Resection with continuity  
 defect.
 Disarticulation section. 
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Some authors describe techniques for decompression and 
marsupialization as similar, without distinguishing them 
as to the principles and method which constitute each one. 
Decompression is the release of the internal pressure of the 
lesion which generates continuity between the external and 
internal environment and the use of a device is necessary. 
This can be attached to the edges of the wound with sutures, 
thus, ensuring this communication is kept open at all times, 
preventing spontaneous closure and allowing sanitation of 
the inner zone of the lesion to prevent bacterial growth or 
accumulation of food. Furthermore, marsupialization com-
prises releasing pressure inside the lesion but one of the main 
principles is to generate a marsupial internal pocket breaking 
all septa either bone or mucus, and making the suture of 
the wound with healthy oral mucosa necessary to maintain 
communication23.
These techniques aim to generate morphological chan-
ges in the capsule through constant trauma due to food 
impaction and constant lavage of the cavity with sterile 
saline solution or 0.12% chlorhexidine, which generates 
swelling of the capsule, making it thicker and more ri-
gid to favor complete removal without leaving traces or 
residues. Along with this, it seeks to cause minor trauma 
regarding the size and tissues involved, trying to protect 
the integrity of important structures. Restoring functio-
nality in the shortest healing time possible is another 
purpose of this technique33,34. 
Decompression has been questioned by some authors, 
since they suggest that not all the affected tissue can be 
removed, and the presence of some satellites cysts or rem-
nants of its membrane can be left in the place34, favoring 
recurrence of injury for reactivation and proliferation of 
these remains. On the other hand, it has been suggested 
that recurrence rates of KCOT undergoing decompres-
sion treatment are similar to cysts undergoing further 
treatment, between 1 and 8.7%3.
Regarding the removal of the device and posterior plan-
ning of the remnant tumor enucleation, the evidence is con-
troversial, since ideally it should be evaluated case by case 
and the evolution of the current treatment should be obser-
ved, keeping in mind the original size after decompression 
of the lesion. The obvious clinical and radiographic changes 
will not be observed in less than 6 months and the treatment 
could even be extended to one year34. 
Morphological changes at macroscopic and microsco-
pic level may be observed in tumors treated by decom-
pression. A macroscopic increase of the tumor membrane 
occurs due to swelling produced by the constant trauma 
generated when exposing the tissue to rub against the 
elements in the oral environment, such as food. Then, a 
thicker and less friable tumor capsule is obtained and it 
allows removal with higher success rates and lower risk of 
residual tumor remaining in cavity35.
Furthermore, the changes occurring at microscopic 
level are increased inf lammatory infiltration in the con-
nective tissue, and epithelial metaplasia due to constant 
injury is observed in the epithelium. The epithelium in-
creases in thickness from the former 6 to 10 cell layers, 
causing epithelial hyperplasia. The epithelium changes 
from a thin parakeratinized epithelium to a hyperplastic 
nonkeratinized squamous epithelium. Bone adherence 
decreases, thus favoring its subsequent release, and stop-
ping to secrete bone resorption factors, osteoclast activi-
ty, and tumor growth. In turn, bone formation begins 
together with a decrease in tumor size, being able to com-
pletely diminish thus making surgery unnecessary. Fur-
thermore, it has been reported that expression of tumor 
growth factors, such as Ki-67, PCNA or p53, decrease 
when undergoing decompressing treatment25,33,35.
The possibility of applying this decompression 
treatment to cystic and tumor pathology of the jaws has 
brought a new option for the management of lesions in 
patients of different ages. In pediatric patients, who are 
growing and their bone bases are not fully established, 
a radical treatment such as resection brings permanent 
consequences for the patient’s life and development. The-
refore, decompression is an option with low morbidity, 
low recurrence rates and in which there is an observed 
reduced lesion size and it may even disappear. A major 
factor in the success of this technique is properly trac-
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king the patient through regular check-ups to clinically 
assess the evolution and remission of the lesion. For this, 
it is necessary to have family support and commitment 
to treatment29.
DISCUSSION. 
KCOT is a benign entity arising from remnants of the 
dental lamina with a relatively high prevalence. It has a 
potential aggressive behavior and a high recurrence rate2,3. 
Multiple authors have reported their invasive potential, due 
to its capacity to slowly grow in the anteroposterior marrow 
spaces, and can be transformed into a large lesion without 
causing notorious expansion2,3.
A noteworthy aspect is its relationship with the basal cell 
nevus syndrome, which is associated with 7% appearing 
mostly in the females3. Apart from associating with multiple 
KCOTs, it can also present basal cell carcinomas, spina bifi-
da and cerebral falx calcification.
Due to the absence of symptoms, it is evident as a radio-
graphic finding during tests or check-ups with panoramic 
radiographs. In imaging studies, they are generally seen as 
a unilocular or multilocular radiolucent area with well-de-
marcated edges4,7. Besides radiography, computed tomogra-
phy and nuclear magnetic resonance with contrast are good 
diagnostic methods. They can be used to assess cortical bone 
perforation or a possible evolution in soft tissues3.
New treatment strategies are still being proposed, 
although they are sometimes controversial. The challenge 
still lies in reducing the risk of recurrence and morbidity 
of an extensive resection18. Recurrence causes are essentia-
lly due to incomplete removal of the cystic membrane and 
growth from small cysts satellites or epithelial nests left af-
ter enucleation19. Multiple treatment modalities have been 
employed in both conservative and radical management of 
KCOTs. Among conservative treatments, it can be found: 
marsupialization or decompression, simple enucleation, enu-
cleation with curettage peripheral (mechanical or chemical), 
decompression followed by enucleation. Radical surgical 
treatments are more aggressive and may comprise marginal 
or block resection, and hemimaxillectomy or hemimandibu-
lectomy24 considering decreased quality of life as a possible 
complication. To prevent recurrence, the use of adjuvants or 
chemical curettage like cryotherapy with liquid nitrogen or 
Carnoy solution has been recommended in order to elimina-
te possible satellite cysts in the bone limits3. The most widely 
used is the Carnoy solution, which penetrates between the 
trabecular bones, devitalizing and attaching tumoral cells24.
According to multiple studies reported in literature, this 
disease presents variable recurrence rates23 which are mostly 
seen in the first five years after surgery19. Higher rates are re-
ported with the single treatment of enucleation (17-56%). If 
it is assisted with Carnoy solution or decompression prior to 
enucleation, it decreases from 1 to 8.7%3,24,30. Finally, resec-
tion is reported as a treatment without recurrences, although 
it is controversial given the benign nature of the disease and 
the numerous associated complications such as facial defor-
mation, tooth loss, infection of the transplanted graft and 
sensory alterations due to damaged nervous elements3,7,24.
CONCLUSION.
Keratocystic odontogenic tumor is now the subject of mul-
tiple studies, which put their main emphasis on its pathologi-
cal aspects, clinical presentation, course and treatment. Since 
this condition does not present any symptoms, early diag-
nosis is critical in order to indicate the optimal treatment to 
slow down evolution and prevent complications. KCOT is 
presented as a pathology that can be mutilating, altering the 
person’s life. Although it does not have a malign nature, it 
generates significant secondary changes and it is necessary to 
seek appropriate treatment from every possible aspect.
Knowing the various aspects of KCOT and using appro-
priate diagnostic means (histopathology and imaging) allow 
a correct diagnosis and treatment of injuries. Therefore, it is 
important that the clinical dentist has the necessary diag-
nostic tools to provide a favorable prognosis for the patient 
through a correct treatment planning.
This review provides essential information for understan-
ding KCOT, aiming to provide a simple summary of the cu-
rrent knowledge about this disease in order to contribute 
to future studies in this area.
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Tumor odontogénico queratoquístico: Aspectos 
clínico-patológicos y tratamiento.
Resumen: El tumor odontogénico queratoquístico es 
una neoplasia intraósea benigna que deriva de restos de la 
lámina dental, y que se presenta con alta frecuencia. Sus 
características histológicas le confieren una elevada tasa 
de recidiva, siendo este uno de sus principales problemas 
terapéuticos. Presenta además una considerable agresivi-
dad local, la cual se expresa con la expansión de corticales 
óseas, retardo en la erupción y desplazamiento de dien-
tes, vasos sanguíneos y nervios. En la actualidad existen 
diversos tratamientos, siendo el ideal aquel que presente 
el menor riesgo de recidiva con una baja morbilidad para 
el paciente. En la presente revisión se discuten los princi-
pales aspectos histopatológicos, clínicos y terapéuticos de 
esta patología oral.
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